BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 8388986)

  • 1. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY; Bergsbaken C
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Hom DS; Loh HH
    J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells.
    Bergsbaken CL; Sommers SL; Law PY
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
    Jin W; Lee NM; Loh HH; Thayer SA
    Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells.
    Costa T; Wüster M; Gramsch C; Herz A
    Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of muscarinic cholinergic receptors in mouse neuroblastoma x rat glioma hybrid cells: rapid induction of enhanced capacity of prostaglandin E1 receptors to stimulate cyclic AMP accumulation.
    Thomas JM; Hoffman BB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):616-22. PubMed ID: 2156056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity.
    Torphy TJ; Zhou HL; Cieslinski LB
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1195-205. PubMed ID: 1335058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling of prostaglandin E1 receptors to the stimulatory GTP-binding protein Gs is enhanced in neuroblastoma x glioma (NG108-15) hybrid cells chronically exposed to an opioid.
    Ammer H; Schulz R
    Mol Pharmacol; 1993 Apr; 43(4):556-63. PubMed ID: 8386308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes.
    Costa T; Klinz FJ; Vachon L; Herz A
    Mol Pharmacol; 1988 Dec; 34(6):744-54. PubMed ID: 2849042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid.
    Lou LG; Pei G
    Biochem Biophys Res Commun; 1997 Jul; 236(3):626-9. PubMed ID: 9245701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonist-induced transient down-regulation of delta-opioid receptors in NG108-15 cells.
    Belcheva MM; Barg J; Gloeckner C; Gao XM; Chuang DM; Coscia CJ
    Mol Pharmacol; 1992 Sep; 42(3):445-52. PubMed ID: 1328845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of delta-opioid receptors with multiple G proteins: a non-relationship between agonist potency to inhibit adenylyl cyclase and to activate G proteins.
    Prather PL; Loh HH; Law PY
    Mol Pharmacol; 1994 May; 45(5):997-1003. PubMed ID: 8190115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.
    Clark MJ; Emmerson PJ; Mansour A; Akil H; Woods JH; Portoghese PS; Remmers AE; Medzihradsky F
    J Pharmacol Exp Ther; 1997 Nov; 283(2):501-10. PubMed ID: 9353363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation.
    Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC
    Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization and resensitization of delta-opioid receptor-mediated Ca2+ channel inhibition in NG108-15 cells.
    Morikawa H; Fukuda K; Mima H; Shoda T; Kato S; Mori K
    Br J Pharmacol; 1998 Mar; 123(6):1111-8. PubMed ID: 9559894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.